Showing results (301-310 of 368) with videos related to
Sort By:
Pageof 37
Circulation. Heart Failure|September 13, 2022
Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population CohortPaul Welsh, Ross T Campbell, Leanne Mooney, et al.Heart Rhythm|July 30, 2013
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbitsKatja E Odening, Bernd A Jung, Corinna N Lang, et al.Neurocritical Care|February 23, 2021
Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry StudyCorinna N Lang, Johanna S Dettinger, Michael Berchtold-Herz, et al.International Journal of Environmental Research and Public Health|January 21, 2023
Feeling Informed and Safe Are Important Factors in the Psychosomatic Health of Frontline Workers in the Health Sector during the COVID-19 Pandemic in AustriaMelanie Lenger, Alexander Maget, Nina Dalkner, et al.European Heart Journal|January 24, 2023
Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish studyJonas Bruhn, Morten Malmborg, Caroline H Garred, et al.Circulation. Cardiovascular Imaging|August 10, 2012
Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experienceShirjel R Alam, Anoop S V Shah, Jennifer Richards, et al.Cardio-Oncology (London, England)|May 20, 2026
Cardio-oncology research prioritisation in the United Kingdom: national surveys of health care professionals, patients and carersGerard M Walls, Allyson Arnold, David Austin, et al.Journal of Clinical Medicine|August 12, 2023
Impact of the COVID-19 Pandemic on Productivity of Workers in the Health Sector between Working in a Hospital and from HomeRobert M Trojak, Melanie Lenger, Armin Birner, et al.Seizure|June 17, 2015
Intravenous levetiracetam in clinical practice--Results from an independent registryN Lang, W Esser, S Evers, et al.European Journal of Cancer (Oxford, England : 1990)|January 8, 2018
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1G M Haag, I Zoernig, J C Hassel, et al.Pageof 37